The Pfizer-BioNTech COVID-19 vaccine candidates were tested in a three-phase clinical trial in 2020, registered on ClinicalTrials.gov with identifying number C4591001.[1]
Investigators
The list of investigators was published as a Supplementary Appendix.[2]
Trial sites
There were 169 official clinical trial sites listed on the trial's ClinicalTrials.gov listing.[1:1] Organizations that served as clinical trial sites included:
- Acevedo Clinical Research Associates
- AMR Mobile
- Anaheim Clinical Trials (ACT)
- Bayview Research Group (BRG)
- California Research Foundation (CRF)
- Chinle Comprehensive Health Care Facility
- Clinical and Translational Science Center (CTSC)
- Clinical Research Consortium (CRC)
- Clinical Research Consulting (CRC)
- Clinical Research of South Florida
- CNS Healthcare
- Collaborative Neuroscience Research (CNS)
- DeLand Clinical Research Unit
- Diablo Clinical Research
- Fleming Island Center for Clinical Research
- Hope Research Institute
- Indago Research and Health Center
- Jacksonville Center for Clinical Research
- Johns Hopkins Center for American Indian Health
- Kaiser Permanente Los Angeles Medical Center
- Kaiser Permanente Northern California
- Kaiser Permanente Santa Clara
- Long Beach Clinical Trials
- Lynn Institute of Denver
- Medical Affiliated Research Center
- National Research Institute
- North Alabama Research Center
- The Pain Center of Arizona
- Paradigm Clinical Research
- Providence Clinical Research
- Research Centers of America
- UC Davis Medical Center
- Whiteriver Indian Hospital
- Yale Center for Clinical Investigation
External links
BioNTech SE, & Pfizer. (2023, February 28). Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Individuals. ClinicalTrials.gov. https://web.archive.org/web/20230420203001/https://clinicaltrials.gov/ct2/show/NCT04368728 ↩︎ ↩︎
Supplementary Appendix (p. 2). (2021). medRxiv. https://web.archive.org/web/20230826041437/https://www.medrxiv.org/content/medrxiv/early/2021/07/28/2021.07.28.21261159/DC1/embed/media-1.pdf ↩︎
